Clinical Trials
2 trialsNCT01195766 2016-02-24
Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Phase 2 Completed
NCT01187303 2015-11-02
Ofatumumab in Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)
University of Cologne
Phase 2 Completed